Liver disease in adult patients with cystic fibrosis: A frequent and independent prognostic factor associated with death or lung transplantation

被引:52
作者
Chryssostalis, Ariane [1 ,2 ]
Hubert, Dominique [3 ,4 ]
Coste, Joel [2 ,5 ]
Kanaan, Reem [3 ,4 ]
Burgel, Pierre-Regis [2 ,3 ,4 ]
Desmazes-Dufeu, Nadine [3 ,4 ]
Soubrane, Olivier [6 ,7 ]
Dusser, Daniel [2 ,3 ,4 ]
Sogni, Philippe [1 ,2 ,4 ,8 ]
机构
[1] Hop Cochin, AP HP, Serv Hepatol, F-75014 Paris, France
[2] Univ Paris 05, Fac Med Paris Descartes, Paris, France
[3] Hop Cochin, AP HP, Serv Pneumol, F-75014 Paris, France
[4] Hop Cochin, Ctr Ressources & Competences Mucoviscidose CRCM A, F-75014 Paris, France
[5] Hop Cochin, AP HP, Unite Rech Clin, F-75014 Paris, France
[6] Univ Paris 06, Fac Med St Antoine, Paris, France
[7] Hop St Antoine, AP HP, Serv Chirurg Hepatobiliaire & Transplantat Hepat, F-75571 Paris, France
[8] Univ Paris 05, Inst Cochin, CNRS UMR 8104, INSERM U 1016, Paris, France
关键词
Liver disease; Cystic fibrosis; Survival; Transplantation; RISK-FACTORS; HEPATITIS-C; PREDICTION; CIRRHOSIS; SURVIVAL; MODEL;
D O I
10.1016/j.jhep.2011.03.028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Increased life expectancy in patients with cystic fibrosis (CF) allows better knowledge of non-pulmonary complications like liver disease (CFLD). However, few data have been published in large adult cohorts. The aim of this study was to estimate the prevalence and the prognosis of CFLD in adult CF patients. Methods: A retrospective analysis of a monocentric cohort of adult CF patients prospectively followed, at least every year, was performed. CFLD was diagnosed using published composite criteria. If cirrhosis was suspected, upper digestive endoscopy was realized to assess the presence of portal hypertension. Results: A cohort of 285 adult CF patients was followed during 4.8 +/- 3.6 years. Among them, 90 had CFLD at the beginning of follow-up and 23 a suspicion of cirrhosis. Factors independently associated with liver disease at baseline were history of meconium ileus, pancreatic insufficiency, chronic colonization with Burkholderia cepacia and the number of IV antibiotic courses per year. Nine patients developed liver decompensation during follow-up, all with a suspicion of cirrhosis at baseline. Six patients underwent liver transplantation alone and three patients combined liver and lung transplantation. Factors independently associated with death or lung transplantation at baseline were liver disease, BMI, forced expiratory volume in 1 second and number of IV antibiotic courses per year. Conclusions: CFLD was present at baseline in one third of adult patients with CF with a marked risk of liver decompensation during follow-up. Moreover, CFLD at baseline appears as an independent factor associated with death or lung transplantation. (C) 2011 European Association for the Study of the Liver. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1377 / 1382
页数:6
相关论文
共 28 条
  • [1] [Anonymous], PAT REG 2006 ANN REP
  • [2] Genetic Modifiers of Liver Disease in Cystic Fibrosis
    Bartlett, Jaclyn R.
    Friedman, Kenneth J.
    Ling, Simon C.
    Pace, Rhonda G.
    Bell, Scott C.
    Bourke, Billy
    Castaldo, Giuseppe
    Castellani, Carlo
    Cipolli, Marco
    Colombo, Carla
    Colombo, John L.
    Debray, Dominique
    Fernandez, Adriana
    Lacaille, Florence
    Macek, Milan, Jr.
    Rowland, Marion
    Salvatore, Francesco
    Taylor, Christopher J.
    Wainwright, Claire
    Wilschanski, Michael
    Zemkova, Dana
    Hannah, William B.
    Phillips, M. James
    Corey, Mary
    Zielenski, Julian
    Dorfman, Ruslan
    Wang, Yunfei
    Zou, Fei
    Silverman, Lawrence M.
    Drumm, Mitchell L.
    Wright, Fred A.
    Lange, Ethan M.
    Durie, Peter R.
    Knowles, Michael R.
    Clancy, J. P.
    Sindel, L. J.
    Roberts, D. M.
    Roberts, V.
    Radford, P. J.
    Argel, N.
    Morgan, W. J.
    Douthit, J. L.
    Schellhase, D. E.
    Anderson, P.
    Taggart, A.
    Morrissey, B.
    Platzker, A. C. G.
    Woo, M. S.
    Fukushima, L.
    Hsu, E.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (10): : 1076 - 1083
  • [3] ANALYSIS OF RISK-FACTORS FOR THE DEVELOPMENT OF LIVER-DISEASE ASSOCIATED WITH CYSTIC-FIBROSIS
    COLOMBO, C
    APOSTOLO, MG
    FERRARI, M
    SEIA, M
    GENONI, S
    GIUNTA, A
    SERENI, LP
    [J]. JOURNAL OF PEDIATRICS, 1994, 124 (03) : 393 - 399
  • [4] Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome
    Colombo, C
    Battezzati, PM
    Crosignani, A
    Morabito, A
    Costantini, D
    Padoan, R
    Giunta, A
    [J]. HEPATOLOGY, 2002, 36 (06) : 1374 - 1382
  • [5] Cystic fibrosis-associated liver disease: A population-based study
    Corbett, K
    Kelleher, S
    Rowland, M
    Daly, L
    Drumm, B
    Canny, G
    Greally, P
    Hayes, R
    Bourke, B
    [J]. JOURNAL OF PEDIATRICS, 2004, 145 (03) : 327 - 332
  • [6] Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension
    Debray, D
    Lykavieris, P
    Gauthier, F
    Dousset, B
    Sardet, A
    Munck, A
    Laselve, H
    Bernard, O
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 (01) : 77 - 83
  • [7] The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid
    Desmond, Christopher Paul
    Wilson, John
    Bailey, Michael
    Clark, Denise
    Roberts, Stuart Keith
    [J]. LIVER INTERNATIONAL, 2007, 27 (10) : 1402 - 1408
  • [8] Clinical Changes of Patients with Cystic Fibrosis during Transition from Pediatric to Adult Care
    Dugueperoux, Ingrid
    Tamalet, Aline
    Sermet-Gaudelus, Isabelle
    Le Bourgeois, Muriel
    Gerardin, Michele
    Desmazes-Dufeu, Nadine
    Hubert, Dominique
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2008, 43 (05) : 459 - 465
  • [9] LIVER-CIRRHOSIS IN CYSTIC-FIBROSIS - THERAPEUTIC IMPLICATIONS AND LONG-TERM FOLLOW-UP
    FEIGELSON, J
    ANAGNOSTOPOULOS, C
    POQUET, M
    PECAU, Y
    MUNCK, A
    NAVARRO, J
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 68 (05) : 653 - 657
  • [10] A prognostic model for the prediction of survival in cystic fibrosis
    Hayllar, KM
    Williams, SGJ
    Wise, AE
    Pouria, S
    Lombard, M
    Hodson, ME
    Westaby, D
    [J]. THORAX, 1997, 52 (04) : 313 - 317